These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16649014)

  • 21. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering from blunt force trauma compared with penetrating trauma: a systematic review.
    Devlin R; Bonanno L; Badeaux J
    JBI Database System Rev Implement Rep; 2016 Mar; 14(3):116-38. PubMed ID: 27532142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies.
    Chu T; Tang Y; Wang H; Qi J; Zhao Y; Pan T; Tang X; Qiu H; Fu C; Ruan C; Wu DP; Han Y
    Thromb Res; 2017 Dec; 160():14-18. PubMed ID: 29080548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of recombinant factor VIIa to facilitate organ donation in trauma patients with devastating neurologic injury.
    Stein DM; Dutton RP; Alexander C; Miller J; Scalea TM
    J Am Coll Surg; 2009 Jan; 208(1):120-5. PubMed ID: 19228513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to control massive abdominal bleeding.
    Busani S; Cavazzuti I; Marietta M; Pasetto A; Girardis M
    Transplant Proc; 2008 May; 40(4):1212-5. PubMed ID: 18555150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
    Zaaroor M; Soustiel JF; Brenner B; Bar-Lavie Y; Martinowitz U; Levi L
    Acta Neurochir (Wien); 2008 Jul; 150(7):663-8. PubMed ID: 18473114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trauma, transfusions, and use of recombinant factor VIIa: A multicenter case registry report of 380 patients from the Western Trauma Association.
    Knudson MM; Cohen MJ; Reidy R; Jaeger S; Bacchetti P; Jin C; Wade CE; Holcomb JB
    J Am Coll Surg; 2011 Jan; 212(1):87-95. PubMed ID: 21115374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
    Fischer D; Schloesser R; Buxmann H; Veldman A
    J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
    White CE; Schrank AE; Baskin TW; Holcomb JB
    Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage.
    Harrison TD; Laskosky J; Jazaeri O; Pasquale MD; Cipolle M
    J Trauma; 2005 Jul; 59(1):150-4. PubMed ID: 16096555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
    Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
    Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of recombinant factor VII in cardiac surgery.
    Elizalde M; Slobodskoy L; Diodato M; Chang J; Chedrawy EG
    Recent Pat Cardiovasc Drug Discov; 2012 Dec; 7(3):216-20. PubMed ID: 22812609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
    Stefanović B; Stefanović B; Mijatović S; Radenković D; Popović N; Sijacki A; Lacković V
    Vojnosanit Pregl; 2009 Nov; 66(11):928-32. PubMed ID: 20017427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
    Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
    Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.